Lower Respiratory Tract Infections Flashcards
1
Q
Definition of LRTI
A
- Any infection of the respiratory tract from the vocal cords downwards - includes:
- Bronchi
- Bronchioles
- Alveoli
- Parenchyma
- Pleura
- Pleural cavities
- Normally bacteriologically sterile
- Inhaled particles including microorganisms are trapped by mucus and moved to the upper respiratory tract by epithelial cilia (mucociliary escalator)
2
Q
Pathogenesis of LRTIs
A
- Paralysis of cilia
- Excessive volume and/or viscosity of mucus - e.g. CF
- LOC, paralysis, ventilation ==> failure to protect LRT
- Failure to cough/loss of swallowing reflex
- “Colonisers” of LRT are often from URT such as:
- Haemophilus influenzae
- Streptococcus pneumoniae
- Antibiotic therapy will affect URT colonisation
3
Q
Acute Bronchitis
A
- Symptoms
- Cough
- Trouble sleeping
- Dyspnoea
- Nasal congestion
- Rhinorrhea
- Sore throat
- Fever (uncommon)
- Causes
- Mostly viral:
- Influenza
- RSV
- Rhinovirus
- Adenovirus
- Parainfluenza virus
- Pertussis - !
- Mostly viral:
4
Q
Chronic Bronchitis
A
- Chronic bronchitis - clinical definition:
- Productive cough for more than 3 months per year for the past 2 years
- Wheezing
- Dyspnoea (SOB)
- Most chronic bronchitis patients develop COPD over time = chronic bronchitis + airflow limitation
5
Q
Chronic Bronchitis - Infective Exacerbations
A
6
Q
Pneumonia - Clinical Features
A
- General:
- Fever/rigors/sweats
- Headache
- Confusion (especially elderly patients)
- Vomiting/diarrhoea
- Localised:
- Breathlessness
- Cough (may be productive)
- Haemoptysis
- Pleuritic chest pains
7
Q
Pneumonia - Investigations
A
- General
- Sats
- ABGs
- FBC
- U&Es
- CRP - useful for monitoring progress of therapy
- CXR
- Microbiological
- Serum - stored acutely 2-3 weeks later used retrospectively to diagnose
- Blood cultures - only positive in 15% of severe cases
- Sputum - shown to be of no clinical value except in cases of TB or Legionella
- Bronchio-alveolar lavage - optimal sample but only used in severe cases as invasive
- Urine - test for antigen to Legionella/S.pneumoniae
8
Q
Pneumonia - Aspiration Pneumonia
A
- Inhalation of material; about 10% of community cases
- Usually neurological problem predisposing
- Commonly affects posterior segment of right upper lobe
- Can lead to abscess formation
- May be associated with chemical pneumonitis - inflammation of the lung caused by inhaling irritants
- Protection of airway important in prevention
- Treat with antibiotics to cover URT flora e.g. penicillin or cephalosporin plus metronidazole
9
Q
Pneumonia - Acute Community Acquired
A
- Common
- If present less than 48 hours into a hospital admission - community acquires
- Most commonly due to:
- Streptococcus pneumoniae
- Haemophilus influenzae
- Specific causative organisms:
- Staphlococcus aureus in flu epidemics
- Kleibsiella pneumoniae in diabetics and alcoholics = severe
- *M.catarrhalis *in COPD
- Sometime viral in children
- Always consider TB
- Narrow spectum therapy
10
Q
Pneumonia - Chronic Community Acquired
A
- Uncommon
- Illness progresses over weeks to months
- TB is the most important cause
- Wide differential including vasculitides
- Specialist assessment needed
11
Q
Community Acquired Pneumonia - Epidemiology
A
- More common in winter
- Male 2:1 female
- More common in elderly
- 750,000 cases a year in UK
- 150,000 consult GP
- 50,000 hospitalised
- 150,000 consult GP
- 10% mortality among hospitalised patients
- Up to 50% mortality if severe
12
Q
Assessing Severity of CAP
A
- CURB-65 score
- Confusion - AMT of 8 or less
- Urea raised > 7mmol/l
- Respiratory rate >30/min
- Blood pressure: systolic <90mmHg +/- diastolic <60mmHg
- 65 and over
- >/= 3 - admit to hospital (mortality 22%)
- 1 or 2 - hospital referral and assessment
- 0 - treat in community
- Additional adverse features:
- Hypoxaemia: PaO2 <8kPa, SaO2 <92%
- Bilateral or multilobar involvement on CXR
13
Q
Typical vs Atypical Pneumonia
A
- Two groups of pathognes
- Respond to different antibiotics
- Clinical spectrums differ
- Cannot tell clinical difference in individual case
- Typical:
- Often lobar
- Caused by: Streptococcus pneumoniae
- Amoxicillin sensitive
- Sometimes macrolide sensitive
- Atypical:
- Often multisystem, multilobar
- Causative organisms: Mycoplasma, Chlamydia, Coxiella, Legionella
- Amoxycillin resistant
- Macrolide sensitive
14
Q
Streptococcus Pneumoniae
A
- Microbiology:
- Gram positive diplococci
- Alpha (incomplete) haemolysis
- Draughtsmen colonies
- Colonises the nose
- Transmitted person-person
- Can invade, causing:
- Pneumonia
- Meningitis
- Endocarditis
- Bacteraemia (may be only manifestation in toddlers)
- Sensitive to: amoxycillin and doxycycline, levofloxacin/moxifloxacin
- Penicillin resistance increasing, although rare in UK
- Significant cause of mortality amongst susceptible individuals e.g elderly, renal failure, splenectomy
- Vaccine available against 23 serogroups plus new heptavalent conjugate vaccine
15
Q
Haemophilus Influenzae
A
- Several serovars resident in the nose
- Transmitted person-person
- Vaccine preventable
- Capsular strain (a-f)
- Associated with invasive infection including, meningitis, epiglottitis (HiB vaccine effective)
- Non-capsular strains
- Associated with mucosal infections including, otitis media, sinusitis and exacerbations of COPD (HiB vaccine ineffective)
- Can invade, causing
- Pneumonia
- Meningitis
- Bacteraemia
- Epiglottitis
- Septic arthritis
-
Requires haem (X) and NAD (V) for growth - Sensitive to amoxicillin
- 20% are b-lactamase positive
- These are sensitive to cefuroxime and co-amoxiclav
- 20% are b-lactamase positive
16
Q
Mycoplasma Pneumoniae
A
- Occurs in epidemics every 3-4 years
- Cause of primary atypical pneumonia
- Human to human transmission
- Most common in children and young adults
- Rare complications include myringitis and encephalitis
- Diagnosis is by serology
- Microbiology:
- Lacks classical peptidoglycan cell wall
- Resistant to beta-lactam antibiotics
- Sensitive to macrolides, tetracyclines and quinolones
17
Q
Legionella Pneumonphila
A
- Can survive and multiply inside macrophages
- Can cause:
- Mild influenza-like URTI = Pontiac fever
- Severe pneumonia with multi-organ failure = Legionnaire’s disease
- >50% of cases associated with travel
- Breeds in stagnant water then spread by cooling tower
18
Q
Chlamydia Pneumoniae and Chlamydia Psittacii
A
- Obligate intracellular parasites
- Sensitive to macrolides, tetracyclines and quinolones
-
C.pneumoniae usually self-limiting and mild
- Human to human transmission
-
C.psittacii can cause severe pneumonia
- Zoonotic infection from birds
- Occupational disease of poultry processing industry
19
Q
Coxiella Burnetii
A
- Causes Q fever
- Spread can be airborne, through infected milk, faeces and urine of farm animals
- Can cause severe pneumonia
- Diagnosis is by serology (Phase 1 and 2 antibodies)
- Can lead to chronic disease and endocarditis
- Best treated with tetracyclines
20
Q
Community Acquired Pneumonia - Empirical Treatment
A
- At home
- Oral
-
Amoxicillin 500mg tds
- Alternatively erythromycin 500mg qds or clarithromycin 500mg bd
-
Amoxicillin 500mg tds
- Oral
- In hospital:
- Oral
-
Amoxicillin 500mg tds plus erythromycin 500mg qds or clarithromycin 500mg bd
- Alternatively *levofloxacin *500mg od
-
Amoxicillin 500mg tds plus erythromycin 500mg qds or clarithromycin 500mg bd
- IV
- Ampicillin 500mg qds or benzypenicillin 1.2g qds plus erythromycin 500mg qds or clarithromycin 500mg bd
- Oral
21
Q
MRSA - Hospital Acquired
A
- Who?
- Elderly
- Debilitated
- Critically/chronically ill
- What?
- Bacteraemia
- UTI
- Skin and soft tissue infection
- How?
- Nosocomial
- Risk factors?
- History of MRSA infection
- Recent surgery
- Admission to a hospital or nursing facility
- Anitbiotic use
- Dialysis
- Permenant indwelling catheter
- Antibiotics
- Multi-drug resistant
- SSCmec (mobile gene element encoding methicillin resistance)
- I
- II
- III
- PVL toxin:
- Rare
22
Q
MRSA - Community Acquired
A
- Who?
- Young healthy people: high school, college and professional athletes
- What?
- Skin and soft tissue infections
- Pneumonia
- How?
- May spread in families and sports teams
- Risk factors?
- Recent antibiotic therapy
- Minor skin trauma
- Unusual grooming habits
- Antibiotics:
- Resistant only to Beta-lactam antibiotics
- SSCmec (mobile gene element encoding methicillin resistance)
- IV
- PVL toxin
- Common
23
Q
PVL S.aureus Pneumonia
A
- Panton-Valentine Leukocidin (PVL) is a cytotoxin produced by some strains of S.aureus that can destroy white blood cells and cause extensive tissue necrosis and severe infection
- Consider PVL S.aurus pneumonia if:
- Previously fit and well
- ‘Flu-like’ illnesss
- Multi-lobar involvement on CXR +/- effusions and cavitation
- Haemoptysis
- Hypotension
- Leucopaenia
- High CRP
- Sputum microscopy showing sheets of staphlococcal-like Gram positive cocci
24
Q
Hospital Acquired Pneumonia
A
- 3rd most common nosocomial infection
- Occurs 0.5-1/100 hospital admissions
- Cause of considerable morbidity/mortality
- Defined as occurring >48 h after admission
- Diagnosed by culture, antigen detection or serology
- Treatment depends on organism involved - if unknown need to cover both S. aureus and P. aeruginosa the two most common causative organisms
- Early onset infection (<5 days following hospital admission) - *co-amoxiclav *or cefuroxime
- If recently on antibiotics or other risk factors then - 3rd generation cephalosporin (*cefotaxime *or ceftriaxone) or a fluoroquinolone or piperacillin/tazobactam
- Early onset infection (<5 days following hospital admission) - *co-amoxiclav *or cefuroxime
25
Pneumonia - Immunocompromised
* Different groups vary in susceptibility to microorgaisms: neutropaenia, HIV, organ transplantation, steroid treatment
* Lack of neutrophils predisposes to:
* Gram negatives eg:
* *Pseudomonas*
* Coliforms
* Gram positives eg:
* *Staphylococcus aureus*
* Viridans streptococci
* Lack of appropriate T-cells predisposes to:
* Intracellular pathogens eg. Mycobacterium species
* Viruses eg. CMV and adenovirus
* Fungi eg. *Cryptococcus neoformans* and *Aspergillus* species
26
Pneumonia - Immunocompromised - Diagnosis and Treatment
* Can be very difficult
* Strenuous attempts should be made to help identify offending pathogen e.g use of CT scan, bronchoscopy, BAL, needle biopsy
* Treatment may have to cover a wide range of pathogens
* Recovery of neutrophil function/T-cell defect will improve prognosis
* Prophylaxis required in selected patients
27
Pneumonia - Pneumocystis Jiroveci (Carinii)

* HIV related illness
* Occurs with CD4
* Fungus: Pneumocystis
* Pneumonia, onset over several days ==\> weeks
* Important cause of death in AIDS
28
Pneumonia - Pneumocystis Jiroveci (Carinii) - Diagnosis and Treatment
* Diagnosis requires induced sputa or BAL sample
* Analysed by cytology
* Pneumocystis can’t be cultured
* Rx:
* Refractory to normal antibiotics
* Responds to co-trimoxazole (Septrin) + steroids
* Prophylaxis given if CD4\< 200
29
Bronchiectasis and Cystic Fibrosis
* Bronchiectasis is due to abnormal structure of bronchi leading to inflammation and obstruction
* Cystic fibrosis leads to abnormal and tenacious mucus in bronchial tree
* Both results in cycles of colonization/ infection/ tissue damage
* Colonising organisms:
* *Staphylococcus aureus*
* *Haemophilus influenzae*
* *Moraxella catarrhalis*
* *Pseudomonas aeruginosa*
* Follow-up involves:
* Montioring clinically
* Further X-rays to:
* Confirm diagnosis
* Exclude complications
30
Lower Respiratory Tract Infections - Complications - Lung Abscess

* May be due to aspiration, pneumonia, haematogenous spread or malignancy
* Aspiration usually polymicrobial
* Haemotogenous abscess usually due to *Staphylococcus aureus*
* Rarer causes include:
* *Klebsiella pneumoniae*
* *Pseudomonas aeruginosa*
* Fungi
31
Lower Respiratory Tract Infections - Complications - Pleural Effusion

* Pleural effusions complication of chronic bronchiecatasis or CF
* Diagnosis made by diagnosic tap to determine types:
* Parapneumonic effusion:
* Reactive - non-infective
* pH\>7.2
* Manage conservatively
* Empyema
* Infected
* pH
* Needs drainage +/- surgery